Index by author

October 01, 1994; Volume 5,Issue 4

A

  1. Allen, S

    1. Lidocaine for the alleviation of pain associated with subcutaneous erythropoietin injection.
      U S Alon, S Allen, Z Rameriz, B A Warady, R A Kaplan and D J Harris
      JASN October 1994, 5 (4) 1161-1162;

  2. Alon, U S

    1. Lidocaine for the alleviation of pain associated with subcutaneous erythropoietin injection.
      U S Alon, S Allen, Z Rameriz, B A Warady, R A Kaplan and D J Harris
      JASN October 1994, 5 (4) 1161-1162;

  3. Amuchastegui, S C

    1. Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started.
      N Perico, S C Amuchastegui, V Colosio, G Sonzogni, T Bertani and G Remuzzi
      JASN October 1994, 5 (4) 1139-1146;

  4. Angeli, P

    1. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
      P L Zhang, W Jiménez, H S Mackenzie, J Guo, J L Troy, J Ros, P Angeli, V Arroyo and B M Brenner
      JASN October 1994, 5 (4) 1099-1105;

  5. Arroyo, V

    1. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
      P L Zhang, W Jiménez, H S Mackenzie, J Guo, J L Troy, J Ros, P Angeli, V Arroyo and B M Brenner
      JASN October 1994, 5 (4) 1099-1105;

B

  1. Baines, A D

    1. Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys.
      A Debska-Slizien, P Ho, R Drangova and A D Baines
      JASN October 1994, 5 (4) 1125-1132;

  2. Bertani, T

    1. Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started.
      N Perico, S C Amuchastegui, V Colosio, G Sonzogni, T Bertani and G Remuzzi
      JASN October 1994, 5 (4) 1139-1146;

  3. Blyden, G

    1. Uptake of atrial natriuretic peptide and production of cGMP in cultured human glomerular endothelial cells.
      D F Green, V A Duruibe, G Blyden, R E Laskey and J J Bourgoignie
      JASN October 1994, 5 (4) 1091-1098;

  4. Bourgoignie, J J

    1. Uptake of atrial natriuretic peptide and production of cGMP in cultured human glomerular endothelial cells.
      D F Green, V A Duruibe, G Blyden, R E Laskey and J J Bourgoignie
      JASN October 1994, 5 (4) 1091-1098;

  5. Braam, B

    1. Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats.
      L G Navar, L Lewis, A Hymel, B Braam and K D Mitchell
      JASN October 1994, 5 (4) 1153-1158;

  6. Brenner, B M

    1. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
      P L Zhang, W Jiménez, H S Mackenzie, J Guo, J L Troy, J Ros, P Angeli, V Arroyo and B M Brenner
      JASN October 1994, 5 (4) 1099-1105;

  7. Brusilow, S W

    1. Unexpected encephalopathy in chronic renal failure: hyperammonemia complicating acute peritonitis.
      J L Pimentel, S W Brusilow and W E Mitch
      JASN October 1994, 5 (4) 1066-1073;

C

  1. Chen, Z

    1. Influence of gender on renal thiazide diuretic receptor density and response.
      Z Chen, D A Vaughn and D D Fanestil
      JASN October 1994, 5 (4) 1112-1119;

  2. Clark, B A

    1. Increased susceptibility to thiazide-induced hyponatremia in the elderly.
      B A Clark, R P Shannon, R M Rosa and F H Epstein
      JASN October 1994, 5 (4) 1106-1111;

  3. Cole, B

    1. Cyclosporine for nephrotic syndrome--isn't it time for a collaborative trial?
      B Cole
      JASN October 1994, 5 (4) 1047-1048;

  4. Colosio, V

    1. Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started.
      N Perico, S C Amuchastegui, V Colosio, G Sonzogni, T Bertani and G Remuzzi
      JASN October 1994, 5 (4) 1139-1146;

D

  1. Debska-Slizien, A

    1. Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys.
      A Debska-Slizien, P Ho, R Drangova and A D Baines
      JASN October 1994, 5 (4) 1125-1132;

  2. Doherty, C C

    1. Linkage disequilibrium between the CA microsatellite D16S283 and PKD1.
      G D Wright, A E Hughes, K A Larkin, C C Doherty and N C Nevin
      JASN October 1994, 5 (4) 1159-1160;

  3. Drangova, R

    1. Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys.
      A Debska-Slizien, P Ho, R Drangova and A D Baines
      JASN October 1994, 5 (4) 1125-1132;

  4. Dunn, M J

    1. Endothelin stimulates mitogen-activated protein kinase activity in mesangial cells through ETA.
      Y Wang, J Pouysségur and M J Dunn
      JASN October 1994, 5 (4) 1074-1080;

  5. Duruibe, V A

    1. Uptake of atrial natriuretic peptide and production of cGMP in cultured human glomerular endothelial cells.
      D F Green, V A Duruibe, G Blyden, R E Laskey and J J Bourgoignie
      JASN October 1994, 5 (4) 1091-1098;

E

  1. Epstein, F H

    1. Increased susceptibility to thiazide-induced hyponatremia in the elderly.
      B A Clark, R P Shannon, R M Rosa and F H Epstein
      JASN October 1994, 5 (4) 1106-1111;

  2. Ercole, L

    1. Decreased glomerulosclerosis in aging by angiotensin-converting enzyme inhibitors.
      L Ferder, F Inserra, L Romano, L Ercole and V Pszenny
      JASN October 1994, 5 (4) 1147-1152;

F

  1. Fanestil, D D

    1. Influence of gender on renal thiazide diuretic receptor density and response.
      Z Chen, D A Vaughn and D D Fanestil
      JASN October 1994, 5 (4) 1112-1119;

  2. Ferder, L

    1. Decreased glomerulosclerosis in aging by angiotensin-converting enzyme inhibitors.
      L Ferder, F Inserra, L Romano, L Ercole and V Pszenny
      JASN October 1994, 5 (4) 1147-1152;

  3. Folger, W H

    1. Renal vasoconstriction with U-46,619; role of arachidonate metabolites.
      C S Wilcox, W H Folger and W J Welch
      JASN October 1994, 5 (4) 1120-1124;

G

  1. Garcia, N H

    1. Angiotensin 1-7 has a biphasic effect on fluid absorption in the proximal straight tubule.
      N H Garcia and J L Garvin
      JASN October 1994, 5 (4) 1133-1138;

  2. Garvin, J L

    1. Angiotensin 1-7 has a biphasic effect on fluid absorption in the proximal straight tubule.
      N H Garcia and J L Garvin
      JASN October 1994, 5 (4) 1133-1138;

  3. Green, D F

    1. Uptake of atrial natriuretic peptide and production of cGMP in cultured human glomerular endothelial cells.
      D F Green, V A Duruibe, G Blyden, R E Laskey and J J Bourgoignie
      JASN October 1994, 5 (4) 1091-1098;

  4. Guo, J

    1. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
      P L Zhang, W Jiménez, H S Mackenzie, J Guo, J L Troy, J Ros, P Angeli, V Arroyo and B M Brenner
      JASN October 1994, 5 (4) 1099-1105;

H

  1. Habib, R

    1. Cyclosporine in the treatment of idiopathic nephrosis.
      P Niaudet and R Habib
      JASN October 1994, 5 (4) 1049-1056;

  2. Harris, D J

    1. Lidocaine for the alleviation of pain associated with subcutaneous erythropoietin injection.
      U S Alon, S Allen, Z Rameriz, B A Warady, R A Kaplan and D J Harris
      JASN October 1994, 5 (4) 1161-1162;

  3. Ho, P

    1. Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys.
      A Debska-Slizien, P Ho, R Drangova and A D Baines
      JASN October 1994, 5 (4) 1125-1132;

  4. Hughes, A E

    1. Linkage disequilibrium between the CA microsatellite D16S283 and PKD1.
      G D Wright, A E Hughes, K A Larkin, C C Doherty and N C Nevin
      JASN October 1994, 5 (4) 1159-1160;

  5. Hymel, A

    1. Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats.
      L G Navar, L Lewis, A Hymel, B Braam and K D Mitchell
      JASN October 1994, 5 (4) 1153-1158;

I

  1. Inserra, F

    1. Decreased glomerulosclerosis in aging by angiotensin-converting enzyme inhibitors.
      L Ferder, F Inserra, L Romano, L Ercole and V Pszenny
      JASN October 1994, 5 (4) 1147-1152;

J

  1. Jiménez, W

    1. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
      P L Zhang, W Jiménez, H S Mackenzie, J Guo, J L Troy, J Ros, P Angeli, V Arroyo and B M Brenner
      JASN October 1994, 5 (4) 1099-1105;

K

  1. Kaplan, R A

    1. Lidocaine for the alleviation of pain associated with subcutaneous erythropoietin injection.
      U S Alon, S Allen, Z Rameriz, B A Warady, R A Kaplan and D J Harris
      JASN October 1994, 5 (4) 1161-1162;

  2. Königer, M

    1. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
      A Krämer-Guth, M Nauck, H Pavenstädt, M Königer, H Wieland, P Schollmeyer and C Wanner
      JASN October 1994, 5 (4) 1081-1090;

  3. Krämer-Guth, A

    1. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
      A Krämer-Guth, M Nauck, H Pavenstädt, M Königer, H Wieland, P Schollmeyer and C Wanner
      JASN October 1994, 5 (4) 1081-1090;

L

  1. Larkin, K A

    1. Linkage disequilibrium between the CA microsatellite D16S283 and PKD1.
      G D Wright, A E Hughes, K A Larkin, C C Doherty and N C Nevin
      JASN October 1994, 5 (4) 1159-1160;

  2. Laskey, R E

    1. Uptake of atrial natriuretic peptide and production of cGMP in cultured human glomerular endothelial cells.
      D F Green, V A Duruibe, G Blyden, R E Laskey and J J Bourgoignie
      JASN October 1994, 5 (4) 1091-1098;

  3. Lewis, L

    1. Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats.
      L G Navar, L Lewis, A Hymel, B Braam and K D Mitchell
      JASN October 1994, 5 (4) 1153-1158;

M

  1. MacAllister, R

    1. Nitric oxide in essential and renal hypertension.
      R MacAllister and P Vallance
      JASN October 1994, 5 (4) 1057-1065;

  2. Mackenzie, H S

    1. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
      P L Zhang, W Jiménez, H S Mackenzie, J Guo, J L Troy, J Ros, P Angeli, V Arroyo and B M Brenner
      JASN October 1994, 5 (4) 1099-1105;

  3. Mitch, W E

    1. Unexpected encephalopathy in chronic renal failure: hyperammonemia complicating acute peritonitis.
      J L Pimentel, S W Brusilow and W E Mitch
      JASN October 1994, 5 (4) 1066-1073;

  4. Mitchell, K D

    1. Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats.
      L G Navar, L Lewis, A Hymel, B Braam and K D Mitchell
      JASN October 1994, 5 (4) 1153-1158;

N

  1. Nauck, M

    1. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
      A Krämer-Guth, M Nauck, H Pavenstädt, M Königer, H Wieland, P Schollmeyer and C Wanner
      JASN October 1994, 5 (4) 1081-1090;

  2. Navar, L G

    1. Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats.
      L G Navar, L Lewis, A Hymel, B Braam and K D Mitchell
      JASN October 1994, 5 (4) 1153-1158;

  3. Nevin, N C

    1. Linkage disequilibrium between the CA microsatellite D16S283 and PKD1.
      G D Wright, A E Hughes, K A Larkin, C C Doherty and N C Nevin
      JASN October 1994, 5 (4) 1159-1160;

  4. Niaudet, P

    1. Cyclosporine in the treatment of idiopathic nephrosis.
      P Niaudet and R Habib
      JASN October 1994, 5 (4) 1049-1056;

P

  1. Pavenstädt, H

    1. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
      A Krämer-Guth, M Nauck, H Pavenstädt, M Königer, H Wieland, P Schollmeyer and C Wanner
      JASN October 1994, 5 (4) 1081-1090;

  2. Perico, N

    1. Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started.
      N Perico, S C Amuchastegui, V Colosio, G Sonzogni, T Bertani and G Remuzzi
      JASN October 1994, 5 (4) 1139-1146;

  3. Pimentel, J L

    1. Unexpected encephalopathy in chronic renal failure: hyperammonemia complicating acute peritonitis.
      J L Pimentel, S W Brusilow and W E Mitch
      JASN October 1994, 5 (4) 1066-1073;

  4. Pouysségur, J

    1. Endothelin stimulates mitogen-activated protein kinase activity in mesangial cells through ETA.
      Y Wang, J Pouysségur and M J Dunn
      JASN October 1994, 5 (4) 1074-1080;

  5. Pszenny, V

    1. Decreased glomerulosclerosis in aging by angiotensin-converting enzyme inhibitors.
      L Ferder, F Inserra, L Romano, L Ercole and V Pszenny
      JASN October 1994, 5 (4) 1147-1152;

R

  1. Rameriz, Z

    1. Lidocaine for the alleviation of pain associated with subcutaneous erythropoietin injection.
      U S Alon, S Allen, Z Rameriz, B A Warady, R A Kaplan and D J Harris
      JASN October 1994, 5 (4) 1161-1162;

  2. Remuzzi, G

    1. Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started.
      N Perico, S C Amuchastegui, V Colosio, G Sonzogni, T Bertani and G Remuzzi
      JASN October 1994, 5 (4) 1139-1146;

  3. Romano, L

    1. Decreased glomerulosclerosis in aging by angiotensin-converting enzyme inhibitors.
      L Ferder, F Inserra, L Romano, L Ercole and V Pszenny
      JASN October 1994, 5 (4) 1147-1152;

  4. Ros, J

    1. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
      P L Zhang, W Jiménez, H S Mackenzie, J Guo, J L Troy, J Ros, P Angeli, V Arroyo and B M Brenner
      JASN October 1994, 5 (4) 1099-1105;

  5. Rosa, R M

    1. Increased susceptibility to thiazide-induced hyponatremia in the elderly.
      B A Clark, R P Shannon, R M Rosa and F H Epstein
      JASN October 1994, 5 (4) 1106-1111;

S

  1. Schollmeyer, P

    1. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
      A Krämer-Guth, M Nauck, H Pavenstädt, M Königer, H Wieland, P Schollmeyer and C Wanner
      JASN October 1994, 5 (4) 1081-1090;

  2. Shannon, R P

    1. Increased susceptibility to thiazide-induced hyponatremia in the elderly.
      B A Clark, R P Shannon, R M Rosa and F H Epstein
      JASN October 1994, 5 (4) 1106-1111;

  3. Sonzogni, G

    1. Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started.
      N Perico, S C Amuchastegui, V Colosio, G Sonzogni, T Bertani and G Remuzzi
      JASN October 1994, 5 (4) 1139-1146;

T

  1. Troy, J L

    1. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
      P L Zhang, W Jiménez, H S Mackenzie, J Guo, J L Troy, J Ros, P Angeli, V Arroyo and B M Brenner
      JASN October 1994, 5 (4) 1099-1105;

V

  1. Vallance, P

    1. Nitric oxide in essential and renal hypertension.
      R MacAllister and P Vallance
      JASN October 1994, 5 (4) 1057-1065;

  2. Vaughn, D A

    1. Influence of gender on renal thiazide diuretic receptor density and response.
      Z Chen, D A Vaughn and D D Fanestil
      JASN October 1994, 5 (4) 1112-1119;

W

  1. Wang, Y

    1. Endothelin stimulates mitogen-activated protein kinase activity in mesangial cells through ETA.
      Y Wang, J Pouysségur and M J Dunn
      JASN October 1994, 5 (4) 1074-1080;

  2. Wanner, C

    1. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
      A Krämer-Guth, M Nauck, H Pavenstädt, M Königer, H Wieland, P Schollmeyer and C Wanner
      JASN October 1994, 5 (4) 1081-1090;

  3. Warady, B A

    1. Lidocaine for the alleviation of pain associated with subcutaneous erythropoietin injection.
      U S Alon, S Allen, Z Rameriz, B A Warady, R A Kaplan and D J Harris
      JASN October 1994, 5 (4) 1161-1162;

  4. Welch, W J

    1. Renal vasoconstriction with U-46,619; role of arachidonate metabolites.
      C S Wilcox, W H Folger and W J Welch
      JASN October 1994, 5 (4) 1120-1124;

  5. Wieland, H

    1. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
      A Krämer-Guth, M Nauck, H Pavenstädt, M Königer, H Wieland, P Schollmeyer and C Wanner
      JASN October 1994, 5 (4) 1081-1090;

  6. Wilcox, C S

    1. Renal vasoconstriction with U-46,619; role of arachidonate metabolites.
      C S Wilcox, W H Folger and W J Welch
      JASN October 1994, 5 (4) 1120-1124;

  7. Wright, G D

    1. Linkage disequilibrium between the CA microsatellite D16S283 and PKD1.
      G D Wright, A E Hughes, K A Larkin, C C Doherty and N C Nevin
      JASN October 1994, 5 (4) 1159-1160;

Z

  1. Zhang, P L

    1. HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
      P L Zhang, W Jiménez, H S Mackenzie, J Guo, J L Troy, J Ros, P Angeli, V Arroyo and B M Brenner
      JASN October 1994, 5 (4) 1099-1105;
Back to top

In this issue

View Selected Citations (0)